This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/SAM-e: Difference between revisions
Jump to navigation
Jump to search
>BronzeManul m Replaced skeletal structure image with standardised svg image. |
>Isaak m Grammatics: Capitalize common names |
||
| (5 intermediate revisions by 4 users not shown) | |||
| Line 40: | Line 40: | ||
<!-- Nomenclature --> | <!-- Nomenclature --> | ||
|NameCommon=S-Adenosyl | |NameCommon=[[common name::S-Adenosyl Methionine]], [[common name::SAM-e]], [[common name::Methylguanidoacetic Acid]] | ||
|NameSubstitution= | |NameSubstitution= | ||
|NameSystematic=(2S)-2-Amino-4-(((2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl)methyl-methylsulfonio)butanoate | |NameSystematic=(2S)-2-Amino-4-(((2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl)methyl-methylsulfonio)butanoate | ||
| Line 54: | Line 54: | ||
|OralROA_Caption= | |OralROA_Caption= | ||
|OralROA_Bioavailability=2-10% | |OralROA_Bioavailability=2-10% | ||
|OralROA_Threshold=[[Oral threshold dose::200]] | |OralROA_Threshold=[[Oral threshold dose::200]] [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral min light dose::400]] - [[Oral max light dose::800]] mg | |OralROA_Light=[[Oral min light dose::400]] - [[Oral max light dose::800]] mg | ||
|OralROA_Common=[[Oral min common dose::800]] - [[Oral max common dose::1200]] mg | |OralROA_Common=[[Oral min common dose::800]] - [[Oral max common dose::1200]] mg | ||
Latest revision as of 08:20, 13 May 2022
| SubstanceBox/SAM-e | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||||||||||||||||||||
| Chemical Nomenclature | |||||||||||||||||||||||||||
| Common names | S-Adenosyl Methionine, SAM-e, Methylguanidoacetic Acid | ||||||||||||||||||||||||||
| Systematic name | (2S)-2-Amino-4-(((2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl)methyl-methylsulfonio)butanoate | ||||||||||||||||||||||||||
| Class Membership | |||||||||||||||||||||||||||
| Psychoactive class | Nootropic | ||||||||||||||||||||||||||
| Chemical class | Nitrogenous organic acid | ||||||||||||||||||||||||||
| Routes of Administration | |||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||